Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · May 05, 2022

Incidence and Management of CAR-T Neurotoxicity in Patients With Multiple Myeloma Treated With Ciltacabtagene Autoleucel

Blood Cancer Journal


Additional Info

Blood Cancer Journal
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies
Blood Cancer J 2022 Feb 24;12(2)32, AD Cohen, S Parekh, BD Santomasso, J Gállego Pérez-Larraya, NWCJ van de Donk, B Arnulf, MV Mateos, N Lendvai, CC Jackson, KC De Braganca, JM Schecter, L Marquez, E Lee, I Cornax, E Zudaire, C Li, Y Olyslager, D Madduri, H Varsos, L Pacaud, M Akram, D Geng, A Jakubowiak, H Einsele, S Jagannath

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading